Navigation Links
STEN Corporation Reports 2008 Third-Quarter Revenue of $5 Million and Improved Results From Operations
Date:8/13/2008

9,393,787 6,555,166

PROPERTY AND EQUIPMENT, NET 1,282,512 1,051,013

OTHER ASSETS

Intangible assets, net 1,073,381 1,228,889

Loan receivable, net of current portion 6,613,197 4,487,466

Other assets 3,695,166 3,990,145

Total Other Assets 11,381,744 9,706,500

TOTAL ASSETS $22,058,043 $17,312,679

LIABILITIES AND STOCKHOLDERS' EQUITY

TOTAL CURRENT LIABILITIES

Line of credit, bank $0 680,000

Current portion of long term debt 5,093,881 2,886,265

Other current liabilities 2,991,048 2,791,762

Total Current Liabilities 8,084,929 6,358,027

LONG-TERM LIABILITIES

Dealer reserves 41,792 1,076,707

Long-term debt, net of current portion 8,948,840 4,457,458

TOTAL LIABILITIES 17,075,561 11,892,192

TOTAL STOCKHOLDERS' EQUITY 4,982,482 5,420,487

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $22,058,043 $17,312,679

NET BOOK VALUE PER SHARE $1.97 $2.72


'/>"/>
SOURCE STEN Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Swine Flu May Not Close College Classrooms 3A CDC 54993 1Swine Flu May Not Close College Classrooms 3A CDC 54993 2Swine Flu May Not Close College Classrooms 3A CDC 54993 3Georgia Reproductive Specialists Free Infertility Seminar 3A Fertility Options 101 54991 1Cornell makes cancer vaccine for clinical use 54990 1Cornell makes cancer vaccine for clinical use 54990 2Cornell makes cancer vaccine for clinical use 54990 3